Exclusive

Publication

Byline

Location

US Patent Issued to Reverb Therapeutics on June 30 for "Cytokine-based therapies and methods" (Canadian Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,668,627, issued on June 30, was assigned to Reverb Therapeutics Inc. (Vancouver, Canada). "Cytokine-based therapies and methods" was invented b... Read More


US Patent Issued to Wake Forest University Health Sciences on June 30 for "SIRP-gamma targeted agents for use in the treatment of cancer" (Chinese, American Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,668,628, issued on June 30, was assigned to Wake Forest University Health Sciences (Winston-Salem, N.C.). "SIRP-gamma targeted agents for use i... Read More


US Patent Issued to PORTSMOUTH MERGER SUB II on June 30 for "Methods of using anti-TREM2 antibodies" (California Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,668,629, issued on June 30, was assigned to PORTSMOUTH MERGER SUB II LLC (Boston). "Methods of using anti-TREM2 antibodies" was invented by Mic... Read More


US Patent Issued to VACCINEX on June 30 for "Human anti-semaphorin 4D antibody" (New York Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,668,630, issued on June 30, was assigned to VACCINEX INC. (Rochester, N.Y.). "Human anti-semaphorin 4D antibody" was invented by Ernest S. Smit... Read More


US Patent Issued to HARBOUR BIOMED (SHANGHAI) on June 30 for "CD3-targeting antibody, bispecific antibody and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,668,631, issued on June 30, was assigned to HARBOUR BIOMED (SHANGHAI) Co. LTD (Shanghai). "CD3-targeting antibody, bispecific antibody and use ... Read More


US Patent Issued to Regeneron Pharmaceuticals on June 30 for "Bispecific anti-MUC16 x anti-CD28 antibodies and uses thereof" (New York Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,668,632, issued on June 30, was assigned to Regeneron Pharmaceuticals Inc. (Tarrytown, N.Y.). "Bispecific anti-MUC16 x anti-CD28 antibodies and... Read More


US Patent Issued to CHIA TAI TIANQING PHARMACEUTICAL GROUP on June 30 for "Bifunctional protein against PD-1 and TGF-Beta" (Chinese Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,668,633, issued on June 30, was assigned to CHIA TAI TIANQING PHARMACEUTICAL GROUP Co. LTD. (Lianyungang City, China). "Bifunctional protein ag... Read More


US Patent Issued to Alpine Immune Sciences on June 30 for "CD80 variant immunomodulatory proteins and uses thereof" (Washington Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,668,634, issued on June 30, was assigned to Alpine Immune Sciences Inc. (Seattle). "CD80 variant immunomodulatory proteins and uses thereof" wa... Read More


US Patent Issued to Arcus Biosciences on June 30 for "Methods of treating solid tumors using an anti-PD-1 antibody or a fragment thereof" (Maryland Inventor)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,668,635, issued on June 30, was assigned to Arcus Biosciences Inc. (Hayward, Calif.). "Methods of treating solid tumors using an anti-PD-1 anti... Read More


US Patent Issued to BERLIN-CHEMIE on June 30 for "Pharmaceutical combinations" (Italian, Swiss Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,668,636, issued on June 30, was assigned to BERLIN-CHEMIE AG (Berlin). "Pharmaceutical combinations" was invented by Monica Binaschi (Rome), Ma... Read More